nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—MAP2K2—salivary gland cancer	0.876	1	CbGaD
Trametinib—MAP2K1—neck—salivary gland cancer	0.00111	0.216	CbGeAlD
Trametinib—MAP2K1—connective tissue—salivary gland cancer	0.000794	0.155	CbGeAlD
Trametinib—MAP2K2—saliva-secreting gland—salivary gland cancer	0.000761	0.148	CbGeAlD
Trametinib—MAP2K1—epithelium—salivary gland cancer	0.000754	0.147	CbGeAlD
Trametinib—MAP2K1—lymphoid tissue—salivary gland cancer	0.000581	0.113	CbGeAlD
Trametinib—MAP2K2—lymphoid tissue—salivary gland cancer	0.000511	0.0998	CbGeAlD
Trametinib—MAP2K1—lymph node—salivary gland cancer	0.000328	0.0639	CbGeAlD
Trametinib—MAP2K2—lymph node—salivary gland cancer	0.000288	0.0563	CbGeAlD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	4.99e-05	0.000421	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PTEN—salivary gland cancer	4.98e-05	0.00042	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	4.96e-05	0.000418	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL17RD—salivary gland cancer	4.93e-05	0.000415	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CYLD—salivary gland cancer	4.91e-05	0.000414	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—PIK3CA—salivary gland cancer	4.91e-05	0.000414	CbGpPWpGaD
Trametinib—MAP2K2—TGF-beta Signaling Pathway—TP53—salivary gland cancer	4.86e-05	0.00041	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by VEGF—HRAS—salivary gland cancer	4.86e-05	0.000409	CbGpPWpGaD
Trametinib—MAP2K2—PDGFR-beta signaling pathway—HRAS—salivary gland cancer	4.86e-05	0.000409	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by Insulin receptor—HRAS—salivary gland cancer	4.82e-05	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	4.82e-05	0.000407	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAML3—salivary gland cancer	4.82e-05	0.000406	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGF16—salivary gland cancer	4.8e-05	0.000405	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	4.77e-05	0.000402	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	4.73e-05	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—FOXO3—salivary gland cancer	4.73e-05	0.000399	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PRKDC—salivary gland cancer	4.71e-05	0.000397	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PTEN—salivary gland cancer	4.67e-05	0.000394	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—NUP62—salivary gland cancer	4.6e-05	0.000388	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	4.56e-05	0.000385	CbGpPWpGaD
Trametinib—MAP2K2—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	4.56e-05	0.000385	CbGpPWpGaD
Trametinib—MAP2K1—TGF-beta Signaling Pathway—TP53—salivary gland cancer	4.55e-05	0.000383	CbGpPWpGaD
Trametinib—MAP2K1—PDGFR-beta signaling pathway—HRAS—salivary gland cancer	4.54e-05	0.000383	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	4.51e-05	0.00038	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAML3—salivary gland cancer	4.51e-05	0.00038	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGF16—salivary gland cancer	4.49e-05	0.000379	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—PIK3CA—salivary gland cancer	4.49e-05	0.000378	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—PIK3CA—salivary gland cancer	4.46e-05	0.000376	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGF16—salivary gland cancer	4.43e-05	0.000374	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by SCF-KIT—HRAS—salivary gland cancer	4.41e-05	0.000372	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—MAP2K2—salivary gland cancer	4.37e-05	0.000368	CbGpPWpGaD
Trametinib—MAP2K2—BDNF signaling pathway—HRAS—salivary gland cancer	4.34e-05	0.000366	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—PIK3CA—salivary gland cancer	4.31e-05	0.000363	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—NUP62—salivary gland cancer	4.31e-05	0.000363	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MC3R—salivary gland cancer	4.29e-05	0.000362	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—PIK3CA—salivary gland cancer	4.29e-05	0.000361	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—PIK3CA—salivary gland cancer	4.27e-05	0.00036	CbGpPWpGaD
Trametinib—MAP2K1—Regulation of Actin Cytoskeleton—PIK3CA—salivary gland cancer	4.27e-05	0.00036	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—PIK3CA—salivary gland cancer	4.27e-05	0.00036	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NUP62—salivary gland cancer	4.25e-05	0.000358	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—PIK3CA—salivary gland cancer	4.25e-05	0.000358	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—PIK3CA—salivary gland cancer	4.22e-05	0.000356	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	4.22e-05	0.000356	CbGpPWpGaD
Trametinib—MAP2K2—Disease—VCAN—salivary gland cancer	4.22e-05	0.000355	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—PIK3CA—salivary gland cancer	4.2e-05	0.000354	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB4—HRAS—salivary gland cancer	4.15e-05	0.00035	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGF16—salivary gland cancer	4.15e-05	0.00035	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ST3GAL4—salivary gland cancer	4.13e-05	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by SCF-KIT—HRAS—salivary gland cancer	4.13e-05	0.000348	CbGpPWpGaD
Trametinib—MAP2K1—BDNF signaling pathway—HRAS—salivary gland cancer	4.06e-05	0.000342	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—PIK3CA—salivary gland cancer	4.03e-05	0.00034	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MC3R—salivary gland cancer	4.02e-05	0.000339	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—PIK3CA—salivary gland cancer	4.01e-05	0.000338	CbGpPWpGaD
Trametinib—MAP2K2—MAPK Signaling Pathway—TP53—salivary gland cancer	4.01e-05	0.000338	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—PIK3CA—salivary gland cancer	3.99e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K2—Insulin Signaling—HRAS—salivary gland cancer	3.99e-05	0.000336	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NUP62—salivary gland cancer	3.98e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	3.97e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	3.97e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—PIK3CA—salivary gland cancer	3.97e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—PIK3CA—salivary gland cancer	3.97e-05	0.000335	CbGpPWpGaD
Trametinib—MAP2K2—Downstream signal transduction—HRAS—salivary gland cancer	3.97e-05	0.000334	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—PIK3CA—salivary gland cancer	3.95e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signaling of activated FGFR—HRAS—salivary gland cancer	3.95e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR—HRAS—salivary gland cancer	3.95e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K2—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	3.95e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K1—Disease—VCAN—salivary gland cancer	3.95e-05	0.000333	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—PIK3CA—salivary gland cancer	3.94e-05	0.000332	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by ERBB2—HRAS—salivary gland cancer	3.93e-05	0.000331	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ISYNA1—salivary gland cancer	3.91e-05	0.00033	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 signaling—HRAS—salivary gland cancer	3.91e-05	0.000329	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	3.9e-05	0.000329	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—PIK3CA—salivary gland cancer	3.89e-05	0.000328	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB4—HRAS—salivary gland cancer	3.89e-05	0.000328	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ST3GAL4—salivary gland cancer	3.87e-05	0.000326	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—MAP2K2—salivary gland cancer	3.86e-05	0.000325	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MAML2—salivary gland cancer	3.85e-05	0.000325	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PTEN—salivary gland cancer	3.84e-05	0.000324	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—NOTCH1—salivary gland cancer	3.83e-05	0.000323	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—PIK3CA—salivary gland cancer	3.76e-05	0.000317	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—DTX4—salivary gland cancer	3.75e-05	0.000316	CbGpPWpGaD
Trametinib—MAP2K1—MAPK Signaling Pathway—TP53—salivary gland cancer	3.75e-05	0.000316	CbGpPWpGaD
Trametinib—MAP2K1—Insulin Signaling—HRAS—salivary gland cancer	3.73e-05	0.000314	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—PIK3CA—salivary gland cancer	3.72e-05	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—PIK3CA—salivary gland cancer	3.72e-05	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—PIK3CA—salivary gland cancer	3.72e-05	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—Downstream signal transduction—HRAS—salivary gland cancer	3.71e-05	0.000313	CbGpPWpGaD
Trametinib—MAP2K1—EGF/EGFR Signaling Pathway—HRAS—salivary gland cancer	3.69e-05	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR—HRAS—salivary gland cancer	3.69e-05	0.000311	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—PIK3CA—salivary gland cancer	3.69e-05	0.000311	CbGpPWpGaD
Trametinib—MAP2K2—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	3.68e-05	0.00031	CbGpPWpGaD
Trametinib—MAP2K2—DAP12 interactions—HRAS—salivary gland cancer	3.68e-05	0.00031	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by FGFR in disease—HRAS—salivary gland cancer	3.68e-05	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by ERBB2—HRAS—salivary gland cancer	3.67e-05	0.00031	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 signaling—HRAS—salivary gland cancer	3.66e-05	0.000308	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—PIK3CA—salivary gland cancer	3.65e-05	0.000308	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR—HRAS—salivary gland cancer	3.64e-05	0.000307	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—PIK3CA—salivary gland cancer	3.64e-05	0.000307	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	3.61e-05	0.000304	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAML2—salivary gland cancer	3.6e-05	0.000304	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by PDGF—HRAS—salivary gland cancer	3.6e-05	0.000303	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PTEN—salivary gland cancer	3.59e-05	0.000303	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—NOTCH1—salivary gland cancer	3.58e-05	0.000302	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FGFR4—salivary gland cancer	3.55e-05	0.000299	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	3.52e-05	0.000297	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—PIK3CA—salivary gland cancer	3.51e-05	0.000296	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—DTX4—salivary gland cancer	3.51e-05	0.000296	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	3.5e-05	0.000295	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FBXW7—salivary gland cancer	3.49e-05	0.000294	CbGpPWpGaD
Trametinib—MAP2K2—Focal Adhesion—HRAS—salivary gland cancer	3.47e-05	0.000293	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—CREBBP—salivary gland cancer	3.47e-05	0.000293	CbGpPWpGaD
Trametinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—HRAS—salivary gland cancer	3.44e-05	0.00029	CbGpPWpGaD
Trametinib—MAP2K1—DAP12 interactions—HRAS—salivary gland cancer	3.44e-05	0.00029	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by FGFR in disease—HRAS—salivary gland cancer	3.44e-05	0.00029	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR—HRAS—salivary gland cancer	3.41e-05	0.000287	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	3.4e-05	0.000287	CbGpPWpGaD
Trametinib—MAP2K1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	3.38e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by EGFR in Cancer—HRAS—salivary gland cancer	3.38e-05	0.000285	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by PDGF—HRAS—salivary gland cancer	3.36e-05	0.000284	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FGFR4—salivary gland cancer	3.32e-05	0.00028	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—PIK3CA—salivary gland cancer	3.29e-05	0.000278	CbGpPWpGaD
Trametinib—MAP2K2—Disease—JAG1—salivary gland cancer	3.29e-05	0.000277	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FGFR4—salivary gland cancer	3.27e-05	0.000276	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FBXW7—salivary gland cancer	3.26e-05	0.000275	CbGpPWpGaD
Trametinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	3.26e-05	0.000275	CbGpPWpGaD
Trametinib—MAP2K1—Focal Adhesion—HRAS—salivary gland cancer	3.25e-05	0.000274	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—CREBBP—salivary gland cancer	3.25e-05	0.000274	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FBXW7—salivary gland cancer	3.22e-05	0.000272	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MARCKS—salivary gland cancer	3.19e-05	0.000269	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—salivary gland cancer	3.18e-05	0.000268	CbGpPWpGaD
Trametinib—MAP2K2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	3.15e-05	0.000265	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGF16—salivary gland cancer	3.1e-05	0.000262	CbGpPWpGaD
Trametinib—MAP2K1—Disease—JAG1—salivary gland cancer	3.08e-05	0.000259	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—CREBBP—salivary gland cancer	3.07e-05	0.000258	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FGFR4—salivary gland cancer	3.06e-05	0.000258	CbGpPWpGaD
Trametinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—HRAS—salivary gland cancer	3.05e-05	0.000257	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FBXW7—salivary gland cancer	3.01e-05	0.000254	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PYGB—salivary gland cancer	2.97e-05	0.00025	CbGpPWpGaD
Trametinib—MAP2K1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—salivary gland cancer	2.94e-05	0.000248	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—FOXO3—salivary gland cancer	2.94e-05	0.000248	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGF16—salivary gland cancer	2.9e-05	0.000245	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—CREBBP—salivary gland cancer	2.87e-05	0.000242	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	2.75e-05	0.000232	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—FOXO3—salivary gland cancer	2.75e-05	0.000232	CbGpPWpGaD
Trametinib—MAP2K2—Disease—FOXO3—salivary gland cancer	2.72e-05	0.000229	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—PIK3CA—salivary gland cancer	2.71e-05	0.000228	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAML2—salivary gland cancer	2.7e-05	0.000227	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—PIK3CA—salivary gland cancer	2.58e-05	0.000217	CbGpPWpGaD
Trametinib—MAP2K2—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	2.55e-05	0.000215	CbGpPWpGaD
Trametinib—MAP2K1—Disease—FOXO3—salivary gland cancer	2.54e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—PIK3CA—salivary gland cancer	2.53e-05	0.000214	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAML2—salivary gland cancer	2.52e-05	0.000213	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by NGF—HRAS—salivary gland cancer	2.51e-05	0.000211	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—MAP2K2—salivary gland cancer	2.46e-05	0.000207	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PHGDH—salivary gland cancer	2.42e-05	0.000204	CbGpPWpGaD
Trametinib—MAP2K1—Cytokine Signaling in Immune system—HRAS—salivary gland cancer	2.38e-05	0.000201	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—EP300—salivary gland cancer	2.36e-05	0.000199	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by NGF—HRAS—salivary gland cancer	2.34e-05	0.000198	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ST3GAL4—salivary gland cancer	2.33e-05	0.000196	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—JAG1—salivary gland cancer	2.3e-05	0.000194	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FGFR4—salivary gland cancer	2.29e-05	0.000193	CbGpPWpGaD
Trametinib—MAP2K2—Axon guidance—HRAS—salivary gland cancer	2.27e-05	0.000191	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FBXW7—salivary gland cancer	2.26e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAP2K2—salivary gland cancer	2.25e-05	0.00019	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—EP300—salivary gland cancer	2.21e-05	0.000186	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PTEN—salivary gland cancer	2.19e-05	0.000185	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—JAG1—salivary gland cancer	2.15e-05	0.000182	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FGFR4—salivary gland cancer	2.15e-05	0.000181	CbGpPWpGaD
Trametinib—MAP2K1—Axon guidance—HRAS—salivary gland cancer	2.12e-05	0.000179	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AQP1—salivary gland cancer	2.11e-05	0.000178	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FBXW7—salivary gland cancer	2.11e-05	0.000178	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	2.1e-05	0.000177	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—EP300—salivary gland cancer	2.09e-05	0.000176	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MAP2K2—salivary gland cancer	2.08e-05	0.000175	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PTEN—salivary gland cancer	2.05e-05	0.000173	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—EP300—salivary gland cancer	1.95e-05	0.000165	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—FOXO3—salivary gland cancer	1.9e-05	0.00016	CbGpPWpGaD
Trametinib—MAP2K2—Disease—NOTCH1—salivary gland cancer	1.82e-05	0.000153	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CREBBP—salivary gland cancer	1.79e-05	0.00015	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—FOXO3—salivary gland cancer	1.78e-05	0.00015	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—CDH1—salivary gland cancer	1.77e-05	0.000149	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MARCKS—salivary gland cancer	1.71e-05	0.000144	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOTCH1—salivary gland cancer	1.7e-05	0.000143	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NUP62—salivary gland cancer	1.68e-05	0.000141	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CREBBP—salivary gland cancer	1.67e-05	0.000141	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—VCAN—salivary gland cancer	1.66e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—CDH1—salivary gland cancer	1.66e-05	0.00014	CbGpPWpGaD
Trametinib—MAP2K2—Disease—CREBBP—salivary gland cancer	1.65e-05	0.000139	CbGpPWpGaD
Trametinib—MAP2K2—Developmental Biology—HRAS—salivary gland cancer	1.62e-05	0.000136	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PYGB—salivary gland cancer	1.59e-05	0.000134	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—PIK3CA—salivary gland cancer	1.54e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Disease—CREBBP—salivary gland cancer	1.54e-05	0.00013	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—HRAS—salivary gland cancer	1.51e-05	0.000128	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	1.46e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAP2K2—salivary gland cancer	1.45e-05	0.000123	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—PIK3CA—salivary gland cancer	1.44e-05	0.000122	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—HRAS—salivary gland cancer	1.43e-05	0.00012	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—HRAS—salivary gland cancer	1.34e-05	0.000113	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PHGDH—salivary gland cancer	1.3e-05	0.000109	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PTEN—salivary gland cancer	1.28e-05	0.000107	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOTCH1—salivary gland cancer	1.27e-05	0.000107	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	1.25e-05	0.000105	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—EP300—salivary gland cancer	1.22e-05	0.000102	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PTEN—salivary gland cancer	1.19e-05	0.000101	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOTCH1—salivary gland cancer	1.19e-05	0.0001	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTEN—salivary gland cancer	1.18e-05	9.92e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CREBBP—salivary gland cancer	1.15e-05	9.73e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—EP300—salivary gland cancer	1.14e-05	9.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AQP1—salivary gland cancer	1.13e-05	9.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—EP300—salivary gland cancer	1.12e-05	9.46e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTEN—salivary gland cancer	1.1e-05	9.28e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CREBBP—salivary gland cancer	1.08e-05	9.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—EP300—salivary gland cancer	1.05e-05	8.85e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	1.04e-05	8.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	9.94e-06	8.38e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CA—salivary gland cancer	9.84e-06	8.3e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CA—salivary gland cancer	9.21e-06	7.76e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—HRAS—salivary gland cancer	9.11e-06	7.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NUP62—salivary gland cancer	9e-06	7.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PIK3CA—salivary gland cancer	8.99e-06	7.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—VCAN—salivary gland cancer	8.93e-06	7.52e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCND1—salivary gland cancer	8.54e-06	7.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—HRAS—salivary gland cancer	8.52e-06	7.18e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3CA—salivary gland cancer	8.42e-06	7.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—HRAS—salivary gland cancer	8.32e-06	7.01e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3CA—salivary gland cancer	8.3e-06	7e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PTEN—salivary gland cancer	8.24e-06	6.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCND1—salivary gland cancer	7.99e-06	6.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—EP300—salivary gland cancer	7.86e-06	6.63e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—HRAS—salivary gland cancer	7.79e-06	6.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3CA—salivary gland cancer	7.77e-06	6.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PTEN—salivary gland cancer	7.71e-06	6.5e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—HRAS—salivary gland cancer	7.68e-06	6.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—EP300—salivary gland cancer	7.36e-06	6.2e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	7.35e-06	6.2e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—HRAS—salivary gland cancer	7.19e-06	6.06e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CREBBP—salivary gland cancer	6.5e-06	5.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CA—salivary gland cancer	5.82e-06	4.9e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TP53—salivary gland cancer	5.63e-06	4.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CA—salivary gland cancer	5.44e-06	4.59e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—HRAS—salivary gland cancer	5.38e-06	4.54e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TP53—salivary gland cancer	5.26e-06	4.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HRAS—salivary gland cancer	5.03e-06	4.24e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTEN—salivary gland cancer	4.64e-06	3.91e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—EP300—salivary gland cancer	4.43e-06	3.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.49e-06	2.94e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CA—salivary gland cancer	3.27e-06	2.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.49e-06	2.1e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—EP300—salivary gland cancer	2.38e-06	2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.76e-06	1.48e-05	CbGpPWpGaD
